|
Status |
Public on Mar 31, 2014 |
Title |
O_lesional_pre-dose |
Sample type |
RNA |
|
|
Source name |
Lesional skin biopsy from psoriasis patient, pre-treatment
|
Organism |
Homo sapiens |
Characteristics |
disease state: psoriasis tissue: lesional skin time: pre-dose patient: O
|
Extracted molecule |
total RNA |
Extraction protocol |
The frozen biopsy was homogenized using a TissueRuptor, and RNA was extracted using the mirVana™ kit with on-column DNase treatment.
|
Label |
biotin
|
Label protocol |
Total RNA was reverse-transcribed and amplified using the NuGen Ovation™ RNA amplification system V2 with Ovation™WB reagent. Amplified RNA was fragmented and labeled using the NuGen FL-Ovation™ cDNA Biotin Module V2. Amplification and labeling were performed on a Beckman-Coulter ArrayPlex.
|
|
|
Hybridization protocol |
Procedure used standard Affymetrix protocol.
|
Scan protocol |
Procedure used standard Affymetrix protocol.
|
Description |
skn48872
|
Data processing |
Scans were imported into Rosetta Resolver and pre-processed using the 'Resolver Affymetrix Rosetta Intensity Profile Builder (saves reporters)' pipeline.
|
|
|
Submission date |
Dec 20, 2013 |
Last update date |
Mar 31, 2014 |
Contact name |
Jeannette Bigler |
E-mail(s) |
[email protected]
|
Organization name |
BJ Group, LLC
|
Street address |
3200 NE 92nd Street
|
City |
Seattle |
State/province |
WA |
ZIP/Postal code |
98115 |
Country |
USA |
|
|
Platform ID |
GPL570 |
Series (1) |
GSE53552 |
Gene expression profiling in psoriatic lesional and non-lesional skin [brodalumab treatment] |
|
Relations |
Reanalysis of |
GSM1021260 |